Triptolide, a diterpenoid derived from Tripterygium wilfordii Hook F, has emerged as a promising anti-cancer agent with diverse mechanisms of action, including the induction of autophagy 28, activation of NF-κB signaling pathway 29 and regulation of CaMKKβ-AMPK signaling pathway 30. Here, CAMKK2 is linked to cancer.